The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
about
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer.Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
P2860
The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The novel biomarker of alterna ...... lications in multiple myeloma.
@en
type
label
The novel biomarker of alterna ...... lications in multiple myeloma.
@en
prefLabel
The novel biomarker of alterna ...... lications in multiple myeloma.
@en
P2093
P1433
P1476
The novel biomarker of alterna ...... plications in multiple myeloma
@en
P2093
Marianne Hokland
Morten N Andersen
Niels Abildgaard
Niels F Andersen
Sidsel Rødgaard-Hansen
P304
P356
10.1016/J.LEUKRES.2015.06.003
P50
P577
2015-06-10T00:00:00Z